-
1.发明授权Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack 有权在患有急性中风或短暂性脑缺血发作降钙素原为细菌感染和抗生素治疗的管理诊断
公开(公告)号：EP2320237B1
公开(公告)日：2016-08-03
申请号：EP10187310.7
申请日：2010-10-12
申请人： B.R.A.H.M.S GmbH
CPC分类号： G01N33/56911 , G01N33/74 , G01N2333/585 , G01N2800/26 , G01N2800/2871 , G01N2800/52
-
2.发明公开Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack 有权在患有急性中风或短暂性脑缺血发作降钙素原为细菌感染和抗生素治疗的管理诊断
公开(公告)号：EP2320237A1
公开(公告)日：2011-05-11
申请号：EP10187310.7
申请日：2010-10-12
申请人： B.R.A.H.M.S GmbH
CPC分类号： G01N33/56911 , G01N33/74 , G01N2333/585 , G01N2800/26 , G01N2800/2871 , G01N2800/52
摘要： The present invention relates to an in vitro method for the diagnosis and treatment guidance of a bacterial infection in patients suffering from an acute ischemic or hemorrhagic stroke, comprising the determination of the level of Procalcitonin (PCT) or a fragment thereof having at least 12 amino acid residues in a sample of a bodily fluid from said patient and the correlation of the determined level to the diagnosis of a bacterial infection in said patient.
摘要翻译： 本发明涉及在体外从急性缺血性或出血性中风的患者的细菌感染的诊断和治疗指导的方法，包括降钙素原（PCT）或其片段的水平的确定它们的具有至少12个 酸残基来自所述患者的体液和确定性开采水平在所述患者的细菌感染的诊断相关的于样品中。
-
搜索结果
2 条记录 (耗时 0.008 秒)
筛选
AND
AND
过滤
NOT
NOT
扫码加群
